AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2016
Aug 25, 2016
31565_dirs_2016-08-25_6e80e4f7-bd0a-440e-b6f5-8fe0f2fa2bbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-08-08
Reporting Person: Burke Willaim P (EVP, Chief Financial Officer)
More from HAEMONETICS CORP
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13